<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">03401</article-id><article-id pub-id-type="doi">10.7554/eLife.03401</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Feature Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Ecology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genes and Chromosomes</subject></subj-group></article-categories><title-group><article-title>Concerning RNA-guided gene drives for the alteration of wild populations</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-16152"><name><surname>Esvelt</surname><given-names>Kevin M</given-names></name><aff><addr-line><named-content content-type="department">Synthetic Biology Platform</named-content></addr-line>, <institution>Wyss Institute for Biologically Inspired Engineering, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country><email>kevin.esvelt@wyss.harvard.edu</email></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-14374"><name><surname>Smidler</surname><given-names>Andrea L</given-names></name><aff><addr-line><named-content content-type="department">Department of Immunology and Infectious Diseases</named-content></addr-line>, <institution>Harvard School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-14375"><name><surname>Catteruccia</surname><given-names>Flaminia</given-names></name><aff><addr-line><named-content content-type="department">Department of Immunology and Infectious Diseases</named-content></addr-line>, <institution>Harvard School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16153"><name><surname>Church</surname><given-names>George M</given-names></name><aff><addr-line><named-content content-type="department">Synthetic Biology Platform</named-content></addr-line>, <institution>Wyss Institute for Biologically Inspired Engineering, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf4"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1191"><name><surname>Tautz</surname><given-names>Diethard</given-names></name><role>Reviewing editor</role><aff><institution>Max Planck Institute for Evolutionary Biology</institution>, <country>Germany</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>07</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e03401</elocation-id><supplementary-material><ext-link xlink:href="elife-03401-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>18</day><month>05</month><year>2014</year></date><date date-type="accepted"><day>09</day><month>07</month><year>2014</year></date></history><permissions><copyright-statement>Copyright Â© 2014, Esvelt et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Esvelt et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Gene drives may be capable of addressing ecological problems by altering entire populations of wild organisms, but their use has remained largely theoretical due to technical constraints.  Here we consider the potential for RNA-guided gene drives based on the CRISPR nuclease Cas9 to serve as a general method for spreading altered traits through wild populations over many generations.  We detail likely capabilities, discuss limitations, and provide novel precautionary strategies to control the spread of gene drives and reverse genomic changes.  The ability to edit populations of sexual species would offer substantial benefits to humanity and the environment.  For example, RNA-guided gene drives could potentially prevent the spread of disease, support agriculture by reversing pesticide and herbicide resistance in insects and weeds, and control damaging invasive species.  However, the possibility of unwanted ecological effects and near-certainty of spread across political borders demand careful assessment of each potential application.  We call for thoughtful, inclusive, and well-informed public discussions to explore the responsible use of this currently theoretical technology.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Kevin M Esvelt, Filed for a patent concerning RNA-guided gene drives.</p></fn><fn fn-type="conflict" id="conf3"><p>Andrea L Smidler, Filed for a patent concerning RNA-guided gene drives.</p></fn><fn fn-type="conflict" id="conf4"><p>George M Church, Filed for a patent concerning RNA-guided gene drives.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></back></article>